More than meets the ear in successful cocktail party conversations

User rating: 5 / 5 after 3 vote(s)

Just picture the scene: you’re at a cocktail party, talking to someone you would like to get to know better but the background noise is making it hard to concentrate. Luckily, humans are very gifted at listening to someone speaking while many other people are talking loudly at the same time. This so-called cocktail-party-phenomenon is based on the ability of the human auditory system to decompose the acoustic world into discrete objects of perception.


Full story »

All News summaries from Medicine & Health news
All News summaries for March 05, 2008

Researchers discover baldness gene: 1 in 7 men at risk

7 hours ago | User rating: not rated yet
Researchers at McGill University, King's College London and GlaxoSmithKline Inc. have identified two genetic variants in caucasians that together produce an astounding sevenfold increase the risk of male pattern baldness. ...

Body's anti-HIV drug explained

7 hours ago | User rating: not rated yet
Humans have a built-in weapon against HIV, but until recently no one knew how to unlock its potential.

Pandemic flu models help determine food distribution and school closing strategies

7 hours ago | User rating: not rated yet
The 1918 flu pandemic killed more than 40 million people worldwide and affected persons of all age groups. While it is difficult to predict when the next influenza pandemic will occur or how severe it will be, researchers ...

Study reveals that signs of heart disease are attributed to stress more frequently in women than men

9 hours ago | User rating: not rated yet
Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), found that coronary heart disease (CHD) symptoms presented ...

Drug may reduce coronary artery plaque

9 hours ago | User rating: not rated yet
Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), suggests that olmesartan, a drug commonly used to treat ...